Minimizing Clonal Variation during Mammalian Cell Line Engineering for Improved Systems Biology Data Generation.

Mammalian cells are widely used to express genes for basic biology studies and biopharmaceuticals. Current methods for generation of engineered cell lines introduce high genomic and phenotypic diversity, which hamper studies of gene functions and discovery of novel cellular mechanisms. Here, we minimized clonal variation by integrating a landing pad for recombinase-mediated cassette exchange site-specifically into the genome of CHO cells using CRISPR and generated subclones expressing four different recombinant proteins. The subclones showed low clonal variation with high consistency in growth, transgene transcript levels and global transcriptional response to recombinant protein expression, enabling improved studies of the impact of transgenes on the host transcriptome. Little variation over time in subclone phenotypes and transcriptomes was observed when controlling environmental culture conditions. The platform enables robust comparative studies of genome engineered CHO cell lines and can be applied to other mammalian cells for diverse biological, biomedical and biotechnological applications.

[1]  Timothy K Lu,et al.  A multi-landing pad DNA integration platform for mammalian cell engineering , 2018, Nucleic acids research.

[2]  F. Leisch,et al.  Changes in Chromosome Counts and Patterns in CHO Cell Lines upon Generation of Recombinant Cell Lines and Subcloning. , 2018, Biotechnology journal.

[3]  M. Andersen,et al.  Using Titer and Titer Normalized to Confluence Are Complementary Strategies for Obtaining Chinese Hamster Ovary Cell Lines with High Volumetric Productivity of Etanercept. , 2018, Biotechnology journal.

[4]  L. Nielsen,et al.  RNA-Seq Highlights High Clonal Variation in Monoclonal Antibody Producing CHO Cells. , 2018, Biotechnology journal.

[5]  Jia Zhao,et al.  Serine Integrases: Advancing Synthetic Biology. , 2018, ACS synthetic biology.

[6]  F. Leisch,et al.  Karyotype variation of CHO host cell lines over time in culture characterized by chromosome counting and chromosome painting , 2018, Biotechnology and bioengineering.

[7]  Suzanne J Gibson,et al.  Transcriptome‐Based Identification of the Optimal Reference CHO Genes for Normalisation of qPCR Data , 2018, Biotechnology journal.

[8]  M. Gossen,et al.  Site-specific chromosomal gene insertion: Flp recombinase versus Cas9 nuclease , 2017, Scientific Reports.

[9]  Lin Zhang,et al.  Strategic deployment of CHO expression platforms to deliver Pfizer's Monoclonal Antibody Portfolio , 2017, Biotechnology progress.

[10]  N. Borth,et al.  Preselection of recombinant gene integration sites enabling high transcription rates in CHO cells using alternate start codons and recombinase mediated cassette exchange , 2017, Biotechnology and bioengineering.

[11]  Mara C Inniss,et al.  A novel Bxb1 integrase RMCE system for high fidelity site‐specific integration of mAb expression cassette in CHO Cells , 2017, Biotechnology and bioengineering.

[12]  Niranjan Nagarajan,et al.  Mammalian Systems Biotechnology Reveals Global Cellular Adaptations in a Recombinant CHO Cell Line. , 2017, Cell systems.

[13]  F. Wurm,et al.  Cloning of CHO Cells, Productivity and Genetic Stability—A Discussion , 2017 .

[14]  Geet Duggal,et al.  Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.

[15]  N. Lewis,et al.  Ribosome profiling-guided depletion of an mRNA increases cell growth rate and protein secretion , 2017, Scientific Reports.

[16]  Daniel C. Zielinski,et al.  A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism. , 2016, Cell systems.

[17]  G. Lee,et al.  Accelerated homology-directed targeted integration of transgenes in Chinese hamster ovary cells via CRISPR/Cas9 and fluorescent enrichment. , 2016, Biotechnology and Bioengineering.

[18]  M. Henry,et al.  Proteomic differences in recombinant CHO cells producing two similar antibody fragments , 2016, Biotechnology and bioengineering.

[19]  D. Schaffer,et al.  Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  Daniel J. Gaffney,et al.  A survey of best practices for RNA-seq data analysis , 2016, Genome Biology.

[21]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.

[22]  M. Andersen,et al.  Versatile microscale screening platform for improving recombinant protein productivity in Chinese hamster ovary cells , 2015, Scientific Reports.

[23]  Baohong Zhang,et al.  Recombinase‐mediated cassette exchange (RMCE) for monoclonal antibody expression in the commercially relevant CHOK1SV cell line , 2015, Biotechnology progress.

[24]  S. Kol,et al.  Development of a VHH-Based Erythropoietin Quantification Assay , 2015, Molecular Biotechnology.

[25]  Lasse Ebdrup Pedersen,et al.  Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway , 2015, Scientific Reports.

[26]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.

[27]  J. Bode,et al.  Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cells , 2014, Applied Microbiology and Biotechnology.

[28]  Alex Toftgaard Nielsen,et al.  Accelerating Genome Editing in CHO Cells Using CRISPR Cas9 and CRISPy, a Web-Based Target Finding Tool , 2014, Biotechnology and bioengineering.

[29]  H. Kim,et al.  A guide to genome engineering with programmable nucleases , 2014, Nature Reviews Genetics.

[30]  G. Smyth,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[31]  Gyun Min Lee,et al.  Development of recombinant Chinese hamster ovary cell lines for therapeutic protein production , 2013 .

[32]  B. G. Hansen,et al.  Microbial production of indolylglucosinolate through engineering of a multi-gene pathway in a versatile yeast expression platform. , 2012, Metabolic engineering.

[33]  K. Hansen,et al.  Sequencing technology does not eliminate biological variability , 2011, Nature Biotechnology.

[34]  H. Hauser,et al.  Rapid Establishment of G-Protein-Coupled Receptor–Expressing Cell Lines by Site-Specific Integration , 2011, Journal of biomolecular screening.

[35]  Hong Zhou,et al.  Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. , 2010, Journal of biotechnology.

[36]  T. Munro,et al.  Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells , 2009, PloS one.

[37]  H. Hauser,et al.  Recombinant protein expression by targeting pre-selected chromosomal loci , 2009, BMC biotechnology.

[38]  Dagmar Wirth,et al.  Road to precision: recombinase-based targeting technologies for genome engineering. , 2007, Current opinion in biotechnology.

[39]  C. Smales,et al.  eIF2alpha phosphorylation, stress perception, and the shutdown of global protein synthesis in cultured CHO cells. , 2005, Biotechnology and bioengineering.

[40]  T. Shibui,et al.  Construction of engineered CHO strains for high-level production of recombinant proteins , 2002, Applied Microbiology and Biotechnology.

[41]  K. Yamamura,et al.  Site-directed integration of the cre gene mediated by Cre recombinase using a combination of mutant lox sites. , 2002, Nucleic acids research.

[42]  H. Hansen,et al.  Improving the secretory capacity of Chinese hamster ovary cells by ectopic expression of effector genes: Lessons learned and future directions. , 2017, Biotechnology advances.

[43]  C. Wilson,et al.  Position effects on eukaryotic gene expression. , 1990, Annual review of cell biology.